Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. REGN
2. CRWD
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. ORCL
10. LYB

Go back to Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Syros Pharmaceuticals (SYRS) Misses Q2 EPS by 13c

August 9, 2022 7:36 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q2 EPS of ($0.54), $0.13 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $6.28 million versus the consensus estimate of $4.74 million.

For earnings history and earnings-related data on Syros Pharmaceuticals (SYRS) click here.

... More